Neuren Pharmaceuticals PWS Study

Neuren Pharmaceuticals Opens Second Trial Site for Phase II PWS Study

Neuren Pharmaceuticals is pleased to announce their second site participating in theirย Phase II, Open Label, PWS Study (Neu-2591-PWS-001) is now open for screening! Important information regarding this exciting milestone: Two sites are now open to enrollment! Rare Disease Research (RDR), located in Atlanta, GA, and Uncommon Cures, located in Chevy Chase, MD (8 miles outside...

Map of States the recognize PWS as a Developmental Disability

Joint Legislation Filed to have PWS Recognized as a Developmental Disability in Ohio

PWSA | USA is excited to announce that thanks to the dedication and hard work of our Advocacy Ambassador, Dr. Erin Carter-Cooper, PhD,ย Ohio Representative Rose Sweeney (D - Districtย 16) and Representative Gayle Mannin (R โ€“ District 52) have jointly filed legislation that will make Prader-Willi syndrome a recognized developmental disability in the State of Ohio!...